{
  "metadata": {
    "contact_id": "CNT-c9M007641",
    "eni_id": "COMBINED-CNT-c9M007641-9ENI",
    "member_name": null,
    "eni_source_type": null,
    "eni_source_subtype": null,
    "generated_at": "2025-08-05T18:13:46.023414",
    "generator": "structured_insight",
    "eni_source_types": [
      "airtable_notes",
      "recurroo"
    ],
    "eni_source_subtypes": [
      "social",
      "asset_class",
      "intro_preferences",
      "null",
      "biography",
      "sector"
    ],
    "system_prompt_key": "structured_insight",
    "context_files": "combined_all_eni_groups",
    "record_count": 9,
    "total_eni_ids": 9
  },
  "insights": {
    "raw_content": "I'll analyze the data and generate a comprehensive member summary with specific insights and proper citations. Here's the updated JSON:\n\n```json\n{\n  \"personal\": \"* Lives between Madison, WI and Captiva, with previous residence in NY (2009-2020)\\n  * [2025-01-08,ENI-09189761397076729792]\\n* Has 3 children with impressive ventures:\\n  * Child running AI startup in SF\\n  * Child operating bike company in Europe\\n  * Child pursuing Psychology PhD at Berkeley\\n  * [2025-01-08,ENI-09189761397076729792]\\n* Accomplished athlete - completed 10+ Ironman races\\n  * [2025-07-29,ENI-07929772741006808018]\\n* Active interests include golf, biking, skiing/snowboarding, tennis, art, travel, watches, wine, and philanthropy\\n  * [2025-07-29,ENI-03647041356388963353]\",\n\n  \"business\": \"* Currently Board Chair at Ascertain and Board Director at multiple companies (Optain, Neuvivo, AIQ Solutions, Aqtual, Verda Bio)\\n  * [2025-07-29,ENI-07929772741006808018]\\n* Former CEO of 4Catalyzer startup accelerator:\\n  * Co-founded and funded 4 companies\\n  * Raised $800M+ in capital\\n  * Led 3 companies to IPO (Butterfly Network, QSi, Hyperfine) with combined $3.5B market cap\\n  * [2025-07-29,ENI-07929772741006808018]\\n* Former President and COO of Ion Torrent (sold for $725M pre-revenue)\\n  * [2025-07-29,ENI-07929772741006808018]\\n* Deep expertise in life sciences:\\n  * Genomics, proteomics, drug development\\n  * Medical technology and diagnostics\\n  * DNA sequencing and molecular diagnostics\\n  * [2025-01-08,ENI-09189761397076729792]\",\n\n  \"investing\": \"* Active board member for 6 early-stage companies\\n  * [2025-01-08,ENI-09189761397076729792]\\n* Focus areas include:\\n  * Healthcare and life sciences (biotech, medtech, molecular diagnostics)\\n  * Artificial Intelligence applications\\n  * Venture capital investments\\n  * [2025-07-29,ENI-8559993876917815106]\\n* Geographic investment interests:\\n  * New York\\n  * California\\n  * Midwest\\n  * [2025-01-08,ENI-1066298016920527153]\\n* Currently raising capital for portfolio companies\\n  * [2025-05-16,ENI-02718822162856553688]\",\n\n  \"3i\": \"* Limited community engagement to date\\n  * [2025-05-16,ENI-02718822162856553688]\\n* Not based in core 3i region\\n  * [2025-05-16,ENI-02718822162856553688]\\n* Values 3i for:\\n  * Network access\\n  * Concierge services\\n  * Investment opportunities\\n  * [2025-01-08,ENI-09189761397076729792]\",\n\n  \"deals\": \"This Member **Has Experience** and Is Comfortable Diligencing These Asset Classes & Sectors\\n- Healthcare/Life Sciences (genomics, diagnostics, medtech)\\n  * [2025-01-08,ENI-09189761397076729792]\\n- Early-stage venture capital\\n  * [2025-07-29,ENI-05883655826784470444]\\n- AI/Technology companies\\n  * [2025-07-29,ENI-8559993876917815106]\\n\\nThis Member **Is Interested In Exploring** These Asset Classes, Sectors, and Strategies\\n- Blockchain/Crypto opportunities\\n  * [2025-07-29,ENI-05883655826784470444]\\n- Private Equity deals\\n  * [2025-07-29,ENI-05883655826784470444]\\n- Real Estate investments\\n  * [2025-07-29,ENI-05883655826784470444]\\n- Credit and Hedge Fund strategies\\n  * [2025-07-29,ENI-05883655826784470444]\\n\\nThis Member **Wants to Avoid** These Asset Classes, Sectors, and Strategies\\n- No specific avoidances noted\\n  * [N/A,ENI-05883655826784470444]\",\n\n  \"introductions\": \"**Looking to meet:**\\n- Venture-focused investors and family offices active in venture capital\\n  * [2025-05-16,ENI-62668947782937195]\\n- Investors and experts in AI, Healthcare, and Life Sciences\\n  * [2025-01-08,ENI-1066298016920527153]\\n- Network connections in NY, California, and Midwest regions\\n  * [2025-01-08,ENI-1066298016920527153]\\n\\n**Avoid introductions to:**\\n- No specific avoidances noted\\n  * [N/A,ENI-1066298016920527153]\"\n}\n```\n\nThis summary integrates all available data points with proper citations, maintaining high specificity in investment preferences and professional background while organizing the information in a clear, structured format. The member's extensive experience in healthcare/life sciences and venture capital is highlighted, along with their broad investment interests across multiple asset classes and sectors."
  }
}